29 Apr, 11:09 - Indian

SENSEX 80354.06 (0.17)

Nifty 50 24367.1 (0.16)

Nifty Bank 55462.05 (0.05)

Nifty IT 35698.5 (0.61)

Nifty Midcap 100 54765.95 (0.60)

Nifty Next 50 65201.7 (0.24)

Nifty Pharma 21802.95 (-0.48)

Nifty Smallcap 100 16803.3 (0.76)

29 Apr, 11:09 - Global

NIKKEI 225 35839.99 (0.38)

HANG SENG 21983 (0.01)

S&P 5568.25 (0.06)

LOGIN HERE

companylogoJubilant Ingrevia Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 543271 | NSE Symbol : JUBLINGREA | ISIN : INE0BY001018 | Industry : Chemicals |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
17-Jan-2025 28-Jan-2025 Quarterly Results Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2025 ,inter alia, to consider and approve Unaudited Financial results for quarter ended 31st December, 2024 and proposal for interim dividend. Board declares interim dividend (As Per BSE Announcement Dated on 28.01.2025)
11-Oct-2024 22-Oct-2024 Quarterly Results Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/10/2024 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results Outcome of Board Meeting Unaudited financial results for quarter ending 30 September 2024 (As Per BSE Announcement Dated on 22.10.2024)
09-Jul-2024 16-Jul-2024 Quarterly Results Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/07/2024 inter alia to consider and approve unaudited Financial Results for the quarter ended 30 June 2024 Approval of unaudited Standalone and Consolidated Financial Results (As Per BSE Announcement dated on 16.07.2024)
26-Jun-2024 26-Jun-2024 Change in Other Executives Appointment of Chief Financial Officer
03-May-2024 14-May-2024 Accounts Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2024 inter alia to consider and approve Intimation for Board Meeting and Final Dividend The Board at its meeting held on May 14, 2024 has recommended the final dividend. Re-appointment of Cost Auditors for FY 2024-25 Record Date is fixed as August 2, 2024 Audited Standalone and Consolidated financial results for the quarter and year ended March 31, 2024 along with Auditors Report (As Per BSE Announcement dated on 14.05.2024)
17-Jan-2024 30-Jan-2024 Quarterly Results Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2024 inter alia to consider and approve Intimation of Board Meeting- January 30 2024 Board of Directors of the Company at its meeting held today at 11:45 am and concluded at 2:45pm Pursuant to applicable provisions of the Listing Regulations, we enclose the following: 1. The Unaudited Financial Results (Standalone and Consolidated) for the quarter ended December 31, 2023; 2. Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said quarter; 3. Declaration for unmodified Auditors' Report (Standalone and Consolidated). 4. The Board has declared an Interim Dividend of Rs.2.50 per equity share of Re. 1 each on the paidup Equity Share capital of the Company for the Financial Year 2023-24. Further, in terms of Regulation 42 of the Listing Regulations, the Board has fixed Friday, February 9, 2024 as Record Date' for the purpose of ascertaining eligibility of the shareholders for payment of Interim Dividend. The Interim Dividend will be paid/ dispatched on or before February 28, 2024. Board Meeting Outcome- Quarterly Results , Interim Dividend Result- Financial Resulr-31.12.2023 Board Approves Dividend Corporate Action- Fixing of Record date for payment of Interim Dividend (As Per BSE Announcement Dated on 30.01.2024)
20-Oct-2023 01-Nov-2023 Quarterly Results Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2023 inter alia to consider and approve Intimation of Board Meeting scheduled to be held on November 01 2023. The unaudited standalone and consolidated financials are attached. The unaudited financial results(standalone & Consolidated) are attached for quarter ended September 30, 2023 (As Per BSE Announcement Dated on 01/11/2023)
11-Aug-2023 18-Aug-2023 Raising funds through Debt Instr. Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/08/2023 inter alia to consider and approve In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Finance Committee of the Company is scheduled to be held on Friday August 18 2023 to consider inter-alia a proposal for raising of funds through Commercial Papers. Members of Finance Committee considered and approved the proposal of raising of funds upto Rs. 600 Crore by issuance of Commercial Paper. (As Per BSE Announcement Dated on: 18/08/2023)
17-Jul-2023 26-Jul-2023 Quarterly Results Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2023 inter alia to consider and approve In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday July 26 2023 to inter-alia consider Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2023. The results are given in the intimation letter attached. Superannuation of Managing Director Appointment of CEO & Managing Director Outcome of Board Meeting (As Per BSE Announcement dated on 26.07.2023)
01-Jun-2023 29-May-2023 Change in Directors Dear Sirs, Reference to our intimation dated May 30, 2023 filed with Stock Exchanges on May 30, 2023, we wish to inform that the Board of Directors of the Company has, at its meeting held on Monday, May 29, 2023, inter-alia, considered and approved the appointment of Mr. Hari S. Bhartia (DIN: 00010499), as Whole-Time Director designated as Executive Co-Chairman effective from June 1, 2023 for a period of 5 years, subject to the approval of shareholders. Accordingly, we request to read 'Whole-Time Director designated as Executive Vice-Chairman' as 'Whole-Time Director designated as Executive Co-Chairman'. Pursuant to Regulation 30 of the SEBI Listing Regulations, we wish to inform that the Board of Directors of the Company has, at its meeting held on Monday, May 29, 2023, inter-alia, considered and approved appointment of Mr. Hari S. Bhartia (DIN: 00010499), as Whole-Time Director designated as Executive Vice-Chairman effective from June 1, 2023 for a period of 5 years, subject to the approval of shareholders. The disclosure required under Regulation 30 of the SEBI (LODR) Regulations, 2015 read with SEBI Circular CIR/CFD/CMD/4/2015 dated September 9, 2015 with respect to Mr. Hari S. Bhartia is enclosed as Annexure-I attached in the intimation letter. (As Per BSE Announcement Dated on 30.05.2023)
08-May-2023 16-May-2023 Accounts Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2023 inter alia to consider and approve In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (the Listing Regulations) we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday May 16 2023 to inter-alia consider: 1. Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31 2023; and 2. Recommendation of Final Dividend for the Financial Year ended March 31 2023 if any. Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulation, 2015, we wish to inform you that the Board of Directors of the Company has, at its meeting held today i.e. May 16, 2023 recommended final dividend of 250% i.e. Rs. 2.50 (Rupees Two and Fifty Paise) per equity share of Re. 1 each for the year ended March 31, 2023. The dividend, if approved by the shareholders at the ensuing Annual General Meeting of the Company, will be paid/ dispatched within 30 days from the date of approval by shareholders at the ensuing annual general meeting (AGM). In terms of Regulation 33 and 52(4) read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2023 were approved by the Board of Directors of the Company at its meeting held today at 11:30 am and concluded at 02:00 pm. We wish to inform that the Board of Directors of the Company has, at its meeting held today i.e. Tuesday, May 16, 2023, considered and approved the following proposals: 1. Appointment of Mr. Chandan Singh Sengar as Co-CEO & Whole-time Director of the Company effective from May 16, 2023 for a period of 5 years. Mr. Singh is not related to any Director of the Company. Brief profile of Mr. Chandan Singh Sengar is given in Annexure-I. In terms of SEBI Letter dated June 14, 2018 read with NSE Circular No. NSE/CML/2018/24 dated June 20, 2018, we wish to confirm that Mr. Chandan Singh is not debarred from holding the office of Director by virtue of any SEBI order or any other authority. 2. Resignation of Mr. Anil Khubchandani as Co- CEO and Whole-time Director of the Company effective from the close of business hours of May 19th, 2023. Details of same are mentioned in the intimation attached. (As Per BSE Announcement dated on 16.05.2023)
23-Jan-2023 31-Jan-2023 Quarterly Results Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2023 inter alia to consider and approve In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday January 31 2023 to inter-alia consider unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31 2022 and declaration of Interim Dividend for the financial year 2022-2023 if any. Please find attached herewith the outcome of the Board Meeting (As Per BSE Announcement Dated on 31/01/2023) We enclose herewith the copies of advertisement published on February 11, 2023 in 'MINT' (English) all Editions and 'HINDUSTAN' (Hindi) Moradabad Edition, with respect to communication to shareholders on deduction of tax at source on Interim Dividend 2022-2023. (As Per BSE Announcement Dated on 13/02/2023)
12-Oct-2022 20-Oct-2022 Quarterly Results Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/10/2022 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half-year ended September 30 2022. Submission of unaudited financial results for period ended September 30, 2022 Unaudited Financial Results for period ended September 30, 2022 (As Per BSE Announcement Dated on 20/10/2022)
28-Jul-2022 05-Aug-2022 Quarterly Results Quarterly Results Jubilant Ingrevia Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2022 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2022. (As Per BSE Announcement dated on 28.07.2022) In terms of Regulations 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2022 were approved by the Board of Directors of the Company at its meeting held today at 11:15 a.m. and concluded at 01:15 p.m. Pursuant to the applicable provisions of the Listing Regulations, we enclose the following: 1. The Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2022; 2. Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said quarter; and; 3. Copies of the Press Release and Presentation. We request you to take the same on records. We wish to inform you that the Board of Directors of the Company has, at its meeting held today i.e. August 5, 2022, fixed the date of Annual General Meeting (the 'AGM') of the Company as Monday, September 26, 2022 through Other Audio Visual Means. Accordingly, in furtherance to our letter dated May 17, 2022, the final dividend, if approved by the shareholders at the ensuing AGM, will be paid/ dispatched on or before October 25, 2022. We request you to take the same on record. (As per BSE Announcement Dated on 05/08/2022) In continuation of our letter dated August 5, 2022, we enclose copies of the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2022 published on August 6, 2022 in MINT (English) and HINDUSTAN (Hindi). We request you to take the same on record. (As Per BSE Announcement Dated on 08/08/2022)
02-Aug-2022 01-Aug-2022 Employee Stock Option Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Nomination, Remuneration and Compensation Committee of the Company has, at its meeting held on Monday, August 1, 2022, granted stock options to the eligible employees as mentioned in the Intimation Letter. In continuation to the Company's letter dated May 17, 2022, we wish to inform you that Board of Directors at its meeting held today, has fixed record date for the purpose of determining the eligibility of the shareholders for the payment of Final Dividend of Rs. 2.50 (Two Rupees and Fifty paisa) per equity share of Re. 1 each for the Financial Year ended March 31, 2022 as per details given below: Record Date - Wednesday, August 24, 2022 The Final dividend, if approved by the shareholders at the ensuing AGM, will be paid/ dispatched on or before October 25, 2022. This is for your information and record. (As per BSE Announcement Dated on 05/08/2022)
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +